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The Reactivity of α-Fluoroketones with PLP Dependent
Enzymes: Transaminases as Hydrodefluorinases
Marina García-Ramos,[a] Aníbal Cuetos,[b, c] Wolfgang Kroutil,*[d] Gideon Grogan,*[b] and
Iván Lavandera*[a]
A chemical method for the treatment of harmful halogenated
compounds that has recently become of interest is the
reductive dehalogenation of carbon-halogen bonds. In the case
of a fluorine atom, this process is called hydrodefluorination.
While many transition metal-based approaches now exist to
reductively defluorinate aromatic fluoroarenes, the cleavage of
C F bonds in aliphatic compounds is not so well-developed.
Here we propose a biocatalytic approach exploiting a promiscu-
ous activity exhibited by transaminases (TAs). Hence, a series of
α-fluoroketones have been defluorinated with excellent con-
versions using Chromobacterium violaceum and Arthrobacter sp.
TAs under mild conditions and in aqueous medium, using a
stoichiometric amount of an amine (e.g. 2-propylamine) as
reagent and formally releasing its oxidized form (e.g. acetone),
with ammonia and hydrogen fluoride as by-products. It is also
demonstrated that this process can be performed in a regio- or
stereoselective fashion.
Introduction
Organic halides are very important compounds due to their
high synthetic versatility as reagents, solvents, and intermedi-
ates in organic synthesis. On one hand, their occurrence as
drug candidates and other biologically active compounds is
prominent,[1] but on the other they can present adverse
properties from an environmental point of view, as they are
slowly degraded. This is especially true for the fluorinated
compounds, as fluorine is currently recognized as one of the
most relevant heteroatoms when included in drug molecules.
This is due to its capacity to modify molecular properties such
as lipophilicity, metabolic stability or acidity, among others,[2]
but also because of its role as a fundamental constituent of
pollutants such chlorofluorocarbons (CFCs).[3] The special prop-
erties that fluorine confers to organic molecules is to a large
extent due to the small size of this atom and the strength of
the C F bonds. Thus, the increasing interest around this
halogen has gone in hand with the development of very
efficient and selective synthetic pathways to obtain fluorinated
compounds.[4]
Due to the inert nature of fluorinated compounds, many
efforts have focused on their degradation, but since oxidative
methods or incineration can produce toxic wastes, reductive
alternatives are envisaged as safer methodologies. Among
them, the cleavage of a C X into a C H bond, i. e.
hydrodehalogenation[3,5] (hydrodefluorination, when X=F),[6,7] is
one of the most promising chemical approaches to degrade
these compounds. When dealing with fluorinated derivatives,
most of these transformations rely on the application of
transition metal complexes under harsh conditions on fluoroar-
ene substrates.[6] Hence, the design of novel methods that
proceed under more environmentally friendly conditions[8] and
that can also reductively defluorinate aliphatic compounds,[9] is
nowadays extremely desirable.
One appealing solution would be the development of
suitable transformations using biocatalysts, since they require in
general mild reaction conditions. In fact, the formation and
cleavage of C X bonds, when X=Cl or Br, mediated by
(de)halogenases, is a valuable synthetic tool that has acquired
significant relevance in recent years.[10] For instance, focusing on
enzymatic dehalogenation reactions,[11] haloalkane
dehalogenases[12] and halohydrin dehalogenases[13] have already
found interesting applications. Also, defluorination processes
have been known to be mediated by enzymes for some
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decades.[14] Fluoroacetate dehalogenases belong to a family of
biocatalysts present in different bacteria which defluorinate
fluoroacetic acid, a natural compound, into glycolic acid
(Scheme 1a),[14] and heme-dependent enzymes such as cyto-
chromes P450 can oxyfunctionalize fluoroarene derivatives into
the corresponding phenolic compounds (Scheme 1b).[15] How-
ever, very few reports have described biocatalytic hydrode-
fluorination reactions.
We recently demonstrated that transaminases (TAs) possess
a promiscuous hydrodefluorinase activity transforming β-fluoro-
amines to the corresponding defluorinated ketones via a
tandem hydrodefluorination–deamination pathway in the ab-
sence of an amine acceptor (Scheme 1c).[16] Due to the
increasing interest in the application of TAs with perfluorinated
substrates to synthesize the corresponding enantioenriched
amines,[17] and the potential activities that β-fluoroamines[18]
present as inhibitors of pyridoxal 5’-phosphate (PLP)-dependent
enzymes,[19] we decided to study the enzymatic synthesis of
these derivatives. The amination of α-fluoroketones using
NADPH-dependent reductive aminases (RedAms) yielded mix-
tures of amine and alcohol products, the latter through direct
reduction of the carbonyl group.[20] In this study, we therefore
considered an alternative approach, in which the TA-catalyzed
transformation of α-fluoroketones would yield exclusively the
β-fluoroamines as products with high conversion and enantio-
meric excess. However, the study has instead revealed that the
TA-dependent transformation of α-fluoroketones leads to
hydrodefluorination to give the ketone products.
Results and Discussion
The initial aim of the study was the TA-catalyzed amination of
α-fluoroacetophenone (1a, 30 mM), which was tested with a set
of 23 transaminases (2 mg) purchased from Codexis Inc. under
typical reaction conditions using 1 M 2-propylamine (2-PrNH2)
as the amine donor to obtain the enantioenriched β-fluoro-
amine (Scheme 2 and Figure S1, Supporting Information).
However, these reactions did not afford the corresponding
aminated compound but rather acetophenone (1b) as the only
product. Just in two cases, 1-phenylethylamine (1c) was also
evolved as a minor co-product. The absence or low production
of amine 1c in these reactions was interesting as 1b is known
to be a good substrate for TAs,[21] suggesting that the hydro-
defluorination process progressed with simultaneous deactiva-
tion of the TAs.[16,19,22] Due to the fact that examples of
hydrodefluorination of α-fluorinated carbonyl compounds are
scarce,[23] and also given the interest in developing a catalytic
alternative under mild conditions in aqueous medium, we
decided to optimize this biotransformation.
In the case of the defluorination of β-fluoroamines, the
addition of an amine acceptor (i. e., acetone) was not
necessary,[16] so we first studied the minimum amount of the
amine donor (2-PrNH2) to achieve high conversions of 1b
starting from 1a. To set up these experiments, lyophilized
whole cells of Escherichia coli containing recombinant TAs from
Chromobacterium violaceum (CV-TA)[24] or Arthrobacter sp. (ArR-
TA)[25] were selected as biocatalysts (10 mg) because they
showed good hydrodefluorinase activity.[16] As can be seen from
the data obtained with CV-TA (Table 1), it was necessary to add
at least a stoichiometric amount of 2-PrNH2 (entry 5) to obtain a
quantitative conversion of 1b. Lower amounts of 2-PrNH2 led to
incomplete formation of the hydrodefluorinated ketone (en-
tries 1–4), and the use of pyridoxamine-5-phosphate (PMP) as
cofactor instead of PLP did not improve the transformation
(entry 2 and Figure S2 in the Supporting Information). It was
Scheme 1. Enzymatic (hydro)defluorination examples.
Scheme 2. Amination vs hydrodefluorination reaction of 1a using trans-
aminases.
Table 1. Effect of the concentration of the amine donor in the hydro-
defluorination process of ketone 1a catalyzed by CV-TA.[a]
Entry [2-PrNH2] [mM] Conversion [%]
[b]
1a 1b 1c
1 – 77 23 <1
2[c] – 87 13 <1
3[d] 10 61 39 <1
4 25 21 79 <1
5 30 <1 >99 <1
6 50 <1 >99 <1
7[d] 50 <1 >99 <1
8 100 <1 >99 <1
[a] For reaction conditions, see the Experimental Section. [b] Measured by
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demonstrated that L-alanine also worked as an activation
reagent (entry 7 and Figure S3 in the Supporting Information).
Similar trends were observed for ArR-TA (Figures S2 and S4).
Moreover, these conditions, in which the concentration of the
amine donor was kept low, together with the concomitant
enzymatic inhibition, abolished the formation of the amine
1c.[26]
The necessity of the amine donor for the hydrodefluorina-
tion of an α-fluorinated ketone, but not of an amine acceptor
for the dehalogenation of a β-fluoroamine, can be explained
with reference to the proposed mechanism (Scheme 3),[16,19] The
main difference between both processes is that whereas the β-
fluoroamine interacts directly with PLP to form the external
aldimine adduct, releasing after a few steps the defluorinated
ketone and PLP,[16] with the hydrodefluorination reaction of an
α-fluoroketone such as 1a, this must react with PMP to produce
the ketimine adduct, which after isomerization into intermedia-
te I and loss of the fluorine atom, gives intermediate II. The
catalytic lysine of the TA can then attack the imine bond to
generate the internal aldimine together with an enamine
derivative, which can further react by one of two different
pathways: it can attack the internal aldimine providing, after
imine hydrolysis, a covalent adduct (III) that will inactivate the
transaminase irreversibly (route a),[27] or it can be simply
hydrolyzed in the reaction medium affording the defluorinated
ketone 1b (route b), with the TA remaining active. Afterwards, a
molecule of the amine reagent (2-PrNH2 in this case) will be
necessary to close the cycle in re-forming the PMP. Overall, the
hydrodefluorination process involves a molecule of an amine
reagent and a water molecule, affording as by-products the
oxidized amine, NH3 and HF.
In order to study the scope of this transformation, various
α-fluoroketones (2–9a) were synthesized following a previously
described methodology.[16,20,28] Based on the results obtained for
the model substrate 1a, we performed the hydrodefluorination
experiments using two different amine concentrations (30 mM
and 100 mM) and CV-TA (10 mg) as catalyst (Figure 1 and
Figure S5).
While enzymatic inactivation proceeds concurrently with
the defluorination reaction, it did not greatly affect the outcome
of the reaction. Although conversions at 30 mM of the amine
donor were usually high (>97% for 6 out of 10 substrates), we
finally selected 100 mM as the optimum concentration, since in
some cases better results were observed (especially for ketones
5a, 6a, and 8a, Figure 1). Different derivatives, including those
bearing electron-donating or electron-withdrawing groups at
the phenyl moiety were obtained with high conversions (>90%
after 24 h) and excellent selectivities, not detecting in any case
the formation of the 1-arylethylamines as co-products. 2-PrNH2
and L-alanine could be used as amine reagents, although
slightly better results were usually attained with 2-propylamine,
especially at 30 mM (Figure S5). It was very interesting to note
that the alkyl C F bond was selectively cleaved even in the
presence of aromatic C Br (4a) or C I (5a) bonds.
In addition, the hydrodefluorination process was demon-
strated to be regioselective for difluorinated ketone 2a, thus
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providing fluoroarene 2b as the only product. This selective
defluorination is particularly challenging by other chemical
means. When we followed a protocol described by Sajiki and
co-workers, previously employed for the hydrodefluorination of
ketone 2b[29] using platinum on carbon in a hydroalcoholic
mixture, but in this case with 2a as substrate, a mixture of
defluorinated ketones 2b and 1b was attained after 4 h
(Figure 2).
We then performed the biotransformation of 2a on a semi-
preparative scale. Thus, 30 mg each of the fluorinated ketones
2a and 6a were defluorinated using E. coli/CV-TA (180–210 mg)
into the corresponding ketones 2b (90% yield) and 6b (40%
yield) after a simple extraction protocol (Experimental Section).
Due to the excellent reactivity and selectivity shown by TAs
with α-fluoroketones in these processes, as the next step we
turned our attention to α-bromo- and α-chloroacetophenone
(10a) as substrates. While the brominated carbonyl compound
was too reactive and formed different by-products even in the
absence of the enzyme, due to its reactivity with the amine
(data not shown), chlorinated ketone 10a was selectively
dehalogenated, forming acetophenone as the only product
(Scheme 4a and Figure S6). Although the reaction proceeded
more slowly in comparison with fluorinated ketone 1a, CV-TA
and ArR-TA (10 mg) were able to quantitatively convert the α-
chloroketone with a slight molar excess of 2-PrNH2 (1.7 to 3.3-
fold). These results demonstrate that TAs can also catalyze a
promiscuous hydrodechlorinase reaction.
One of the properties of enzyme-catalyzed reactions most
valued by organic chemists is their excellent stereoselectivity.
We hence envisaged the possibility of employing TAs as
catalysts for stereoselective hydrodefluorination processes. To
the best of our knowledge, there is no report regarding an
enantioselective hydrodefluorination reaction on fluorinated
alkyl compounds,[30] apart from the tandem hydrodefluorina-
tion-deamination process on β-fluoroamines described by our
groups.[16] An exhaustive enzymatic screening was done with
11a under different reaction conditions (Tables S1 and S2), and
while in most cases modest enantioselectivities were observed,
a variant of Arthrobacter sp. transaminase, ArRmut11-TA
(10 mg),[17e] defluorinated this substrate to give propiophenone
(11b), and residual 11a with an enantiomeric excess of up to
80% (Scheme 4b). This is a very interesting result because the
transaminase must discriminate between the groups at the α
position of the reacting center (a methyl and a fluorine atom),
which are not very different in size. In addition, this chiral
ketone can slowly racemize over time in the reaction medium
(Figure S7), so this result likely underestimates the enzyme
selectivity. It should also be noted that in some cases 1-
phenylpropan-1-amine and an unknown by-product were also
detected, but usually with low conversions (<20%).
Figure 1. Conversions measured by GC in the hydrodefluorination reaction
of α-fluoroketones 1–9a to give dehalogenated ketones 1–9b catalyzed by
CV-TA using 2-propylamine (dark blue) or L-alanine (light blue) at 100 mM
concentration.
Figure 2. Hydrodefluorination of 2a employing Pt/C. Color code: green 2a,
purple 2b, blue 1b.
Scheme 4. a) Hydrodehalogenation of α-chloroacetophenone (10a) cata-
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Conclusions
The selective hydrodefluorination of α-fluoroketones or alde-
hydes is a difficult transformation as these carbonyl compounds
are highly reactive, and apart from the C F bond reduction, the
C=O bond can also be reduced. In fact, most of the reported
catalytic hydrodefluorination protocols rely on the use of
transition metal complexes over fluoroarene or alkenyl sub-
strates under harsh reaction conditions. Recently, we described
a tandem hydrodefluorination–deamination reaction on β-
fluoroamines due to the promiscuous catalytic hydrodefluor-
inase activity shown by TAs. Following this study, we have now
applied these enzymes to cleave the C F bond in various α-
fluoroketones to give the corresponding defluorinated ketones
with high conversions under very mild conditions and in
aqueous medium. To achieve this goal, a stoichiometric amount
of an amine reagent (e. g., 2-PrNH2) was necessary, affording the
oxidized amine (e. g., acetone), ammonia and hydrogen fluoride
as co-products. This transformation has proven to be chemo-
selective (reducing a C F vs C=O bond) as well as regioselective
(breaking an aliphatic C F vs an aromatic C F bond) and
stereoselective (preferentially defluorinating an enantiomer of a
chiral fluorinated alkyl compound). To improve these processes,
enzyme engineering could be envisaged as a method for
gaining access to more stereoselective hydrodefluorinases for
the synthesis of enantiopure α-fluoro carbonyl derivatives.
Experimental Section
General enzymatic hydrodehalogenation protocol: In an Eppen-
dorf tube, the corresponding transaminase [commercial TA (2 mg),
or lyophilized cells overexpressing the TA (10 mg)] was placed, and
then a mixture of phosphate buffer (100 mM, pH 7.5, 1 mM PLP)
with the desired concentration of the amine donor (2-propylamine
or D- or L-alanine, 30–100 mM) and DMSO (12.5 μL, final volume:
0.5 mL) were added. Finally, the corresponding substrate 1–11a
(30 mM) was added into the reaction mixture, and it was shaken at
30 °C and 250 rpm for 24 h in an orbital shaker. The reaction was
stopped by addition of a saturated aqueous solution of Na2CO3
(350 μL) and extracted with ethyl acetate (3×350 μL). The organic
layers were separated by centrifugation (14,400 rpm), combined
and dried over Na2SO4. The conversion was measured by GC-FID
(see the Supporting Information for analytical conditions).
Hydrodefluorination of 2a and 6a at semi-preparative scale: In an
Erlenmeyer flask, lyophilized cells of E. coli/CV-TA (for 2a: 210 mg
and for 6a: 180 mg) were placed and then a mixture of phosphate
buffer (100 mM, pH 7.5, 30 mM 2-PrNH2, 1 mM PLP) and MeCN (for
2a: 160 μL, final volume: 6.4 mL and for 6a: 165 μL, final volume:
6.6 mL). Finally, the corresponding substrates 2a and 6a (30 mg,
30 mM) were added into the reaction mixture, and it was shaken at
30 °C and 250 rpm for 45 h in an orbital shaker. Conversion was
measured by GC-FID (see the Supporting Information for analytical
conditions). The reaction was extracted with EtOAc (6×6 mL) until
there was no organic product in the aqueous phase (confirmed by
TLC). Organic phases were combined, dried over anhydrous Na2SO4
and the solvent removed under reduced pressure affording
dehalogenated products 2b (24 mg, 90% yield) and 6b (11 mg,
40% yield). 1H-NMR spectra of the obtained products were
compared with samples of the commercially available ketones.
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The hydrodefluorination of various α-
fluoroketones has been performed
under mild reaction conditions and
in aqueous medium taking
advantage of the promiscuous
activity shown by transaminases
using a stoichiometric amount of,
e.g. 2-propylamine, releasing in this
case acetone, ammonia and
hydrogen fluoride as by-products.
The process could be done in a
regio- or even in a stereoselective
manner.
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